2009年3月16日 星期一

Atherosclerosis is the principal cause of heart disease and a leading cause of stroke, making it the most common cause of death in the U.S. [2008](IR92)_FNKWs_{hydrogen peroxide, H2O2}

Atherosclerosis is the principal cause of heart disease and a leading cause of stroke, making it the most common cause of death in the U.S. [2008](IR92)

Atherosclerosis is the principal cause of heart disease and a leading cause of stroke, making it the most common cause of death in the U.S. [2008](IR92)_FNKWs_{hydrogen peroxide, H2O2}
http://www.vascularpath.org/projects.htm

// - - Begin memo item - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - //
(Memo Item created on March 17, 2009 12:39 PM)
- - - Begin title or keyword:
Key points mentioned in this article
- - - End title or keyword:

Essentially all risk factors for atherosclerosis result in the enhanced generation of hydrogen peroxide in the vessel wall by the activation of membrane bound NADPH oxidases (NOX). The NADPH oxidases generate superoxide in the extracellular space that both inactivates nitric oxide and is dismutated into hydrogen peroxide by extracellular superoxide dismutase (ECSOD).

// - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - End memo item - - //
// - - Begin memo item - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - //
(Memo Item created on January 15, 2009 02:33 PM)
- - - Begin title or keyword:
Atherosclerosis is the principal cause of heart disease and a leading cause of stroke, making it the most common cause of death in the U.S.

http://www.vascularpath.org/projects.htm
- - - End title or keyword:

Home | Projects | Lab Members | Publications | Links | Biographical Sketch | Contact

Projects


Atherosclerosis is the principal cause of heart disease and a leading cause of stroke, making it the most common cause of death in the U.S. The laboratory is seeking to understand the biochemical processes resulting in atherosclerosis in order to combat this pervasive disease.

Atherosclerosis is characterized by the development of necrotic/lipid cores within the intima of arteries at particular sites in the circulation. These necrotic/lipid cores form in the setting of a pre-existing intimal hyperplasia, characterized by the proliferation of smooth muscle-like cells within the intima. The laboratory is investigating both the mechanisms of signal transduction responsible for the formation of the pre-atherosclerotic intimal hyperplasia, as well as the factors stimulating the formation of intimal necrotic/lipid cores. Signal Transduction with Hydrogen Peroxide in Vascular Cells

Essentially all risk factors for atherosclerosis result in the enhanced generation of hydrogen peroxide in the vessel wall by the activation of membrane bound NADPH oxidases (NOX). The NADPH oxidases generate superoxide in the extracellular space that both inactivates nitric oxide and is dismutated into hydrogen peroxide by extracellular superoxide dismutase (ECSOD). These low physiologic levels of hydrogen peroxide are mitogenic, stimulating vascular cell growth and proliferation.


The mechanisms by which low endogenous levels of hydrogen peroxide stimulate cellular proliferation are currently poorly understood. The laboratory is using proteomic approaches with cultured vascular cells to identify signal transduction pathways activated by low physiologic levels of hydrogen peroxide. One target protein identified is the nuclear pre-mRNA binding protein hnRNP-C. Low physiologic levels of hydrogen peroxide stimulate the hyperphosphorylation of the acidic C-terminal domain of hnRNP-C, resulting in diminished ability of the protein to bind mRNA. The effect is mediate by protein kinase CK1 Other groups have previously shown that hnRNP-C is hyperphosphorylated during mitosis, and that CK1 entry into the nucleus is required for cell cycle progression. Proteomic Analyses of Intimal Hyperplasia from Atherosclerosis-Prone and Atherosclerosis-Resistant Human Arteries

Pre-atherosclerotic intimal hyperplasia forms at branch sites both in arteries prone to develop atherosclerosis, such as the internal carotid and coronary arteries and also in vessels remarkably resistant to the formation of atherosclerosis, such as the internal thoracic artery and the distal ulnar artery. The structural variations in intimal hyperplasia that may facilitate the development of atherosclerosis have been unclear. Proteoglycans have been implicated as playing a direct role in atherosclerosis, both by binding and retaining lipoproteins in the vessel wall and by regulating cell growth. One project in the laboratory has been to analyze by mass spectrometry the extracellular proteoglycans present in pre-atherosclerotic intimal hyperplasia from atherosclerosis-prone arteries as well as atherosclerosis-resistant arteries. This project has revealed the proteoglycan composition of human intimal hyperplasia to be more complex than previously realized with eight distinct proteoglycans present: perlecan, versican, aggrecan, biglycan, decorin, fibromodulin, lumican, and prolargin. Importantly, while most of the proteoglycans are present at similar levels in the two arterial types, there is a selective enhanced deposition of lumican proteoglycan in the pre-atherosclerotic intimal hyperplasia from the atherosclerosis-prone artery compared with the intimal hyperplasia from the atherosclerosis-resistant artery. This data
suggests that lumican may play a central role in the development of atherosclerotic lesions in humans, and may partly account for site-specific susceptibility to atherosclerosis. Home | Projects | Lab Members | Publications | Links | Biographical Sketch | Contact


Massachusetts General Hospital | Simches Building, Rm 8236
185 Cambridge Street, CPZN | Boston, MA 02114
Phone: 617-726-8303 | Fax: 617-726-2365

©2007 James R. Stone Lab - Department of Pathology - Massachusetts General Hospital

Site by: AlternaSite

// - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - End memo item - - //


2009-03-17

File Index: 0001
Original file name (原始的檔案名稱):
Atherosclerosis is the principal cause of heart disease and a leading cause of stroke, making it the most common cause of death in the U.S. [2008](IR92)_FNKWs_{hydrogen peroxide, H2O2} 01.PNG
GUID file name:
FN_A2CF01CC1B6F4534A8DADDFEC29A9CE5.PNG

File Index: 0002
Original file name (原始的檔案名稱):
Atherosclerosis is the principal cause of heart disease and a leading cause of stroke, making it the most common cause of death in the U.S. [2008](IR92)_FNKWs_{hydrogen peroxide, H2O2} 02.png
GUID file name:
FN_D5294A18D4D24C23A8C6ABB84D7C8027.png

File Index: 0003
Original file name (原始的檔案名稱):
Atherosclerosis is the principal cause of heart disease and a leading cause of stroke, making it the most common cause of death in the U.S. [2008](IR92)_FNKWs_{hydrogen peroxide, H2O2} 03.png
GUID file name:
FN_C87B4CCEB3624598A61178DB66955278.png


Keywords:
Hydrogen peroxide, increased, glutathione (GSH), L-Cysteine, Atherosclerosis (【醫學】動脈粥狀硬化), cardiovascular (【醫學】心血管性的), stroke (中風)

Number of attached files: 
3

2009年3月9日 星期一

The major determinants (決定因素) of GSH synthesis are the availability of cysteine, and the activity of the rate-limiting enzyme, g-glutamylcysteine synthetase (GCS)[1999](IR90)

 
The major determinants (決定因素) of GSH synthesis are the availability of cysteine, and the activity of the rate-limiting enzyme, g-glutamylcysteine synthetase (GCS)[1999](IR90)
 

Regulation of hepatic glutathione synthesis: current concepts and controversies SHELLY C. LU

USC Liver Disease Research Center, the Division of Gastrointestinal (胃腸的) and Liver Diseases, Department of Medicine, University of Southern California School of Medicine, Los Angeles, California 90033, USA

 

ABSTRACT

 

Glutathione (GSH) is an important intracellular peptide with multiple functions ranging from antioxidant defense to modulation of cell proliferation. GSH is synthesized in the cytosol (【生物學】細胞溶質) of all mammalian (哺乳動物(的)) cells in a tightly regulated manner. The major determinants (決定因素) of GSH synthesis are the availability of cysteine, the sulfur amino acid precursor, and the activity of the rate-limiting enzyme, g-glutamylcysteine synthetase (GCS). In the liver, major factors that determine the availability of cysteine are diet, membrane transport activities of the three sulfur amino acids cysteine, cystine and methionine, and the conversion of methionine to cysteine via the trans-sulfuration pathway. Many conditions alter GSH level via changes in GCS activity and GCS gene expression. These include oxidative stress, activators of Phase II detoxifying enzymes, antioxidants, drug-resistant tumor cell lines, hormones, cell proliferation, and diabetes mellitus (糖尿病). Since the molecular cloning (複製) of GCS, much has been learned about the regulation of this enzyme. Both transcriptional and post-transcriptional mechanisms modulate the activity of this critical cellular enzyme.

 

Lu, S. C. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J. 13, 1169-1183 (1999)

 

Key Words:

g-glutamylcysteine synthetase , cysteine availability , detoxification , antioxidant

2009年2月20日 星期五

Effect of ageing on human plasma glutathione concentrations as determined by high-performance liquid chromatography with fluorimetric detection [1995](IR94).doc

Effect of ageing on human plasma glutathione concentrations as determined by high-performance liquid chromatography with fluorimetric detection [1995](IR94).doc

Effect of ageing on human plasma glutathione concentrations as determined by high-performance liquid chromatography with fluorimetric detection [1995](IR94)


// - - Begin memo item - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - //
(Memo Item created on February 20, 2009 02:33 PM)
- - - Begin title or keyword:
Effect of ageing on human plasma glutathione concentrations as determined by high-performance liquid chromatography with fluorimetric detection [1995](IR94)

http://highwire.stanford.edu/cgi/medline/pmid;8749248?maxtoshow=&HITS=&hits=&RESULTFORMAT=&fulltext=Effect+of+ageing+on+human+plasma+glutathione+concentrations&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
- - - End title or keyword:

Effect of ageing on human plasma glutathione concentrations as determined by high-performance liquid chromatography with fluorimetric detection.
CS Yang, ST Chou, L Liu, PJ Tsai, and JS Kuo
J Chromatogr B Biomed Appl, December 1, 1995; 674(1): 23-30.    

Department of Medical Research. Taichung Veterans General Hospital Taiwan (
台中榮民總醫院).

A convenient method for the determination of reduced glutathione (GSH) and oxidized glutathione (GSSG) in human plasma by high-performance liquid chromatography with fluorescence detection is reported. This assay involves direct addition of human plasma to methanolic monobromobimane, for simultaneous protein precipitation and thiol derivatization. The assay was validated by addition of authentic GSH and GSSG to plasma samples. Plasma glutathione levels in Chinese male and female volunteers were found to decrease with increasing age (age groups 20-30, 30-40, 40-50, 50-60, and > 60; mean +/- S.E.M. 0.95 +/- 0.03, 0.77 +/- 0.02, 0.67 +/- 0.03, 0.51 +/- 0.02, 0.48 +/- 0.02 microM for male volunteers and 1.11 +/- 0.06, 0.76 +/- 0.03, 0.61 +/- 0.03, 0.53 +/- 0.04 and 0.43 +/- 0.04 microM for female volunteers). GSSG levels, in both males and females, did not show a correlation with age. There were no significant differences in GSH or GSSG levels among male and female volunteers of the same age group. These results suggest that elderly persons might be more susceptible to oxidative injury due to decreased plasma glutathione levels.

Publication Types:

Journal article
Research support, non-u.s. gov't
MeSH Terms:

Adult
Aged
Aging
Bicyclo Compounds
Chromatography, High Pressure Liquid*
Dithiothreitol
Ethylmaleimide
Female
Fluorometry
Glutathione
Humans
Male
Middle Aged
Reproducibility of Results
Sulfhydryl Reagents
PMID: 8749248

--------------------------------------------------------------------------------
MEDLINE data is licensed by HighWire Press from the National Library of Medicine. Some material in the NLM databases is from copyrighted publications of the respective copyright claimants. Users of the NLM databases are solely responsible for compliance with any copyright restrictions and are referred to the publication data appearing in the bibliographic citations, as well as to the copyright notices appearing in the original publications, all of which are hereby incorporated by reference.
// - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - End memo item - - //


2009年1月8日 星期四

[沛體旺-C (Hythiol-C)]_{西元2006年,在日本國內[美白用維他命製劑]的市場佔有率第一名之認證資料}(R1.01)[2006-12-08](IR90).doc


2009-01-08

File Index: 0001
Original file name (原始的檔案名稱):
[沛體旺-C (Hythiol-C)]_{西元2006年,在日本國內[美白用維他命製劑]的市場佔有率第一名之認證資料}(R1.01)[2006-12-08](IR90).doc
GUID file name:
FN_886F5C0A1A3948B9B673EC7FBF143112.doc


Keywords:
[沛體旺-C (Hythiol-C)]_{西元2006年,在日本國內[美白用維他命製劑]的市場佔有率第一名之認證資料}(R1.01)[2006-12-08](IR90).doc

Number of attached files: 
1

 

2008年11月9日 星期日

Glutathione - Systemic Protectant Against Oxidative and Free Radical Damage (IR96)[2008-10-22]


Glutathione - Systemic Protectant Against Oxidative and Free Radical Damage (IR96)[2008-10-22]

November 10, 2008; 02:09:45 p.m. Taipei Time

The glutathione status of a cell will perhaps turn out to be the most accurate single indicator of the health of a cell (IR90)[2008-11-01]{P}.png

Cysteine is a rate-limiting precursor for GSH synthesis (IR90)[2008-11-10].PNG

2008年8月13日 星期三

Articles with keywords_{Glutathione, depletion, ...} [2008-08-14]

 
[2008-08-14-PM-01-14-46]
Articles with keywords_{coke, depletion, cataract (【醫】白內障)} [2008-07-09].PNG
Articles with keywords_{Glutathione depletion, asthma (氣喘)}[2008-08-01].PNG
Articles with keywords_{Glutathione depletion, autism (自閉症)}[2008-08-01].PNG
Articles with keywords_{Glutathione depletion, DNA mutations (突變), cancer (癌症)}[2008-07-17].PNG
Articles with keywords_{Glutathione depletion, gastric cancer (胃癌)} [2008-07-21].PNG
Articles with keywords_{Glutathione depletion, heavy mental (沉重的精神)}[2008-08-01](IR85).PNG
Articles with keywords_{Glutathione depletion, heavy metal (重金屬)}[2008-08-01](IR85).PNG
Articles with keywords_{Glutathione, depletion, Bladder Cancer (膀胱癌)} [2008-07-23].PNG
Articles with keywords_{Glutathione, depletion, breast, cancer (乳癌)} [2008-07-09].PNG
Articles with keywords_{glutathione, depletion, cadmium (【化】鎘)} [2008-08-14].PNG
Articles with keywords_{Glutathione, depletion, cataract (【醫】白內障)} [2008-07-09].PNG
Articles with keywords_{Glutathione, depletion, cirrhosis (肝硬化)}[2008-08-06].PNG
Articles with keywords_{Glutathione, Depletion, colon cancer (結腸癌)}[2008-07-01].PNG
Articles with keywords_{Glutathione, depletion, Colorectal Cancer (大腸癌)} [2008-07-23].PNG
Articles with keywords_{Glutathione, Depletion, coronary 冠狀動脈的(心臟病)}[2008-06-27].PNG
Articles with keywords_{Glutathione, Depletion, diabetes (糖尿病)}[2008-06-27].PNG
Articles with keywords_{glutathione, depletion, dioxin (戴奧辛)} [2008-08-14].PNG
Articles with keywords_{glutathione, depletion, lead (鉛), metal} [2008-08-14].PNG
Articles with keywords_{Glutathione, depletion, melanoma (黑色素瘤)} [2008-07-24].PNG
Articles with keywords_{Glutathione, depletion, melanoma (黑色素瘤)}[2008-07-13].PNG
Articles with keywords_{glutathione, depletion, mercury (【化】水銀, 汞)} [2008-08-14].PNG
Articles with keywords_{Glutathione, depletion, Pancreatic cancer (胰臟癌, 胰腺癌)}[2008-08-03].PNG
Articles with keywords_{Glutathione, Depletion, 骨頭缺血性壞死症 (骨頭壞死症)(osteonecrosis)}[2008-07-29].PNG
Children with autism have low levels of glutathione and cysteine (the pre-cursor to glutathione) [2008-08-01](IR90).PNG

2008年7月30日 星期三

The different aspects of the biological role of glutathione (IR90)[2007-07]


The different aspects of the biological role of glutathione (IR90)[2007-07]
Document Type: Research article


The different aspects of the biological role of glutathione (IR90)[2007-07]

http://www.ncbi.nlm.nih.gov
/pubmed/17679914?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

[The different aspects of the biological role of glutathione][Article in Polish]
Bilska A, Kryczyk A, Włodek L.
Katedra Biochemii Lekarskiej Uniwersytetu Jagiellońskiego Collegium Medicum w Krakowie.

Glutathione plays a key role in maintaining a physiological balance between prooxidants and antioxidants, crucial for the life and death of a cell. Glutathione occurs in the human body in several redox forms, of which reduced glutathione (GSH), oxidized glutathione (GSSG), S-nitrosoglutathione (GSNO), and mixed disulfides of glutathione with proteins are the most important. There is a clear relationship between the levels of different redox forms of glutathione and the regulation of cellular metabolism in a broad sense. Therefore, each of these forms of glutathione can be beneficial or harmful to the organism depending on the cell type and its metabolic status. In such a situation, elevation of GSH level can constitute a very important factor aiding treatment. A rise in GSH level is beneficial in all pathological states, accompanied by lowered GSH content, while a lowering of GSH level is an indication to induce short-term immunosuppression required in organ transplantation and in tumor cells to selectively increase their sensitivity to chemo- and radiotherapy. GSH itself cannot be used as a therapeutic since it is not transported through plasma membranes. Cysteine, an amino acid which limits glutathione biosynthesis, also cannot be used in therapy due to its high neurotoxicity. For this reason, there is currently an intensive search for possibilities of modulating cellular glutathione and cysteine levels, and this problem can be the subject of interdisciplinary studies combining such scientific fields as biology, pharmacology, toxicology, and clinical medicine.

PMID: 17679914 [PubMed - indexed for MEDLINE]